BRIANA EVANS: Open Payments
NPI 1275151540 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 22 payments from 12 companies in 2025. Trend: 2023 $1,457 · 2024 $717 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $151 |
| ABBVIE INC. | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Antares Pharma, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Lundbeck LLC | 1 | $24 |
| ILLUMINOSS MEDICAL, INC. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| Insulet Corporation | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: Wegovy, REXULTI, VRAYLAR, UBRELVY, XYOSTED, SPRAVATO, Ozempic, VYEPTI.
Industry payments across GA — which companies pay providers there.
